Aileron Therapeutics Inc

NASDAQ:ALRN  
0.42
+0.02 (+5.00%)
Earnings Announcements

Aileron Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results And Provides Business Highlights

Published: 03/28/2022 21:43 GMT
Aileron Therapeutics Inc (ALRN) - Aileron Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights.
Aileron Therapeutics - Expects, Existing Cash, Cash Equivalents and Investments Will Fund Operations Into Q4 of 2023.
Aileron Therapeutics Inc - Qtrly Net Loss per Share $0.08.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.09

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.10

More details on our Analysts Page.